{"transactions":[{"id":4639529,"issuer":{"id":3781,"kind":"organization","name":"Oruka Therapeutics, Inc.","symbol":"ORKA"},"owners":[{"id":23523,"kind":"person","name":"Agarwal Arjun","position":1,"cik":"0002033974","reported_name":"Agarwal Arjun","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President, Finance"}}],"security":"Employee Stock Option (right to buy)","published_at":"2026-10-13T20:34:29.000Z","date":"2026-10-12","kind":"exercise","planned":true,"acquired":false,"shares":1458,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The option vests as to 1/48 of the underlying shares monthly from January 1, 2026."}],"balance_after":56875,"derivative":{"exercise_price":34.39,"expiration_date":"2036-01-22","underlying":"Common Stock","underlying_shares":1458},"source":{"system":"sec-edgar","filing":"0000907654-26-000106","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/2033974/000090765426000106/form4.xml","form_type":"4"}},{"id":4639528,"issuer":{"id":3781,"kind":"organization","name":"Oruka Therapeutics, Inc.","symbol":"ORKA"},"owners":[{"id":23523,"kind":"person","name":"Agarwal Arjun","position":1,"cik":"0002033974","reported_name":"Agarwal Arjun","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President, Finance"}}],"security":"Employee Stock Option (right to buy)","published_at":"2026-10-13T20:34:29.000Z","date":"2026-10-12","kind":"exercise","planned":true,"acquired":false,"shares":8541,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The option vests as to 1/48 of the underlying shares monthly from January 1, 2025."}],"balance_after":76376,"derivative":{"exercise_price":12.5,"expiration_date":"2035-01-21","underlying":"Common Stock","underlying_shares":8541},"source":{"system":"sec-edgar","filing":"0000907654-26-000106","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/2033974/000090765426000106/form4.xml","form_type":"4"}},{"id":4639527,"issuer":{"id":3781,"kind":"organization","name":"Oruka Therapeutics, Inc.","symbol":"ORKA"},"owners":[{"id":23523,"kind":"person","name":"Agarwal Arjun","position":1,"cik":"0002033974","reported_name":"Agarwal Arjun","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President, Finance"}}],"security":"Common Stock","published_at":"2026-10-13T20:34:29.000Z","date":"2026-10-12","kind":"sale","planned":true,"acquired":false,"shares":200,"price":82.835,"value":16567.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These sales were effected pursuant to a Rule 10b5-1 trading plan entered into on February 11, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $82.76 to $82.91, inclusive."}],"balance_after":14219,"source":{"system":"sec-edgar","filing":"0000907654-26-000106","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/2033974/000090765426000106/form4.xml","form_type":"4"}},{"id":4639526,"issuer":{"id":3781,"kind":"organization","name":"Oruka Therapeutics, Inc.","symbol":"ORKA"},"owners":[{"id":23523,"kind":"person","name":"Agarwal Arjun","position":1,"cik":"0002033974","reported_name":"Agarwal Arjun","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President, Finance"}}],"security":"Common Stock","published_at":"2026-10-13T20:34:29.000Z","date":"2026-10-12","kind":"sale","planned":true,"acquired":false,"shares":1958,"price":81.8551,"value":160272.2858,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These sales were effected pursuant to a Rule 10b5-1 trading plan entered into on February 11, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $81.61 to $82.50, inclusive."}],"balance_after":14419,"source":{"system":"sec-edgar","filing":"0000907654-26-000106","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/2033974/000090765426000106/form4.xml","form_type":"4"}},{"id":4639525,"issuer":{"id":3781,"kind":"organization","name":"Oruka Therapeutics, Inc.","symbol":"ORKA"},"owners":[{"id":23523,"kind":"person","name":"Agarwal Arjun","position":1,"cik":"0002033974","reported_name":"Agarwal Arjun","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President, Finance"}}],"security":"Common Stock","published_at":"2026-10-13T20:34:29.000Z","date":"2026-10-12","kind":"sale","planned":true,"acquired":false,"shares":2100,"price":80.7601,"value":169596.21,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These sales were effected pursuant to a Rule 10b5-1 trading plan entered into on February 11, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $80.56 to $81.53, inclusive."}],"balance_after":16377,"source":{"system":"sec-edgar","filing":"0000907654-26-000106","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/2033974/000090765426000106/form4.xml","form_type":"4"}},{"id":4639524,"issuer":{"id":3781,"kind":"organization","name":"Oruka Therapeutics, Inc.","symbol":"ORKA"},"owners":[{"id":23523,"kind":"person","name":"Agarwal Arjun","position":1,"cik":"0002033974","reported_name":"Agarwal Arjun","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President, Finance"}}],"security":"Common Stock","published_at":"2026-10-13T20:34:29.000Z","date":"2026-10-12","kind":"sale","planned":true,"acquired":false,"shares":5741,"price":80.0302,"value":459453.3782,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These sales were effected pursuant to a Rule 10b5-1 trading plan entered into on February 11, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $79.55 to $80.54, inclusive. The reporting person undertakes to provide to Oruka Therapeutics, Inc., any security holder of Oruka Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3), (4) and (5) to this Form 4."}],"balance_after":18477,"source":{"system":"sec-edgar","filing":"0000907654-26-000106","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2033974/000090765426000106/form4.xml","form_type":"4"}},{"id":4639523,"issuer":{"id":3781,"kind":"organization","name":"Oruka Therapeutics, Inc.","symbol":"ORKA"},"owners":[{"id":23523,"kind":"person","name":"Agarwal Arjun","position":1,"cik":"0002033974","reported_name":"Agarwal Arjun","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President, Finance"}}],"security":"Common Stock","published_at":"2026-10-13T20:34:29.000Z","date":"2026-10-12","kind":"exercise","planned":true,"acquired":true,"shares":1458,"price":34.39,"value":50140.62,"ownership":{"direct":true},"balance_after":24218,"source":{"system":"sec-edgar","filing":"0000907654-26-000106","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2033974/000090765426000106/form4.xml","form_type":"4"}},{"id":4639522,"issuer":{"id":3781,"kind":"organization","name":"Oruka Therapeutics, Inc.","symbol":"ORKA"},"owners":[{"id":23523,"kind":"person","name":"Agarwal Arjun","position":1,"cik":"0002033974","reported_name":"Agarwal Arjun","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President, Finance"}}],"security":"Common Stock","published_at":"2026-10-13T20:34:29.000Z","date":"2026-10-12","kind":"exercise","planned":true,"acquired":true,"shares":8541,"price":12.5,"value":106762.5,"ownership":{"direct":true},"balance_after":22760,"source":{"system":"sec-edgar","filing":"0000907654-26-000106","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2033974/000090765426000106/form4.xml","form_type":"4"}},{"id":4623630,"issuer":{"id":3781,"kind":"organization","name":"Oruka Therapeutics, Inc.","symbol":"ORKA"},"owners":[{"id":23523,"kind":"person","name":"Agarwal Arjun","position":1,"cik":"0002033974","reported_name":"Agarwal Arjun","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President, Finance"}}],"security":"Common Stock","published_at":"2026-09-21T21:38:50.000Z","date":"2026-09-21","kind":"sale","planned":true,"acquired":false,"shares":533,"price":95.75,"value":51034.75,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These sales were effected pursuant to a Rule 10b5-1 trading plan entered into on February 11, 2026."}],"balance_after":14219,"source":{"system":"sec-edgar","filing":"0000907654-26-000102","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2033974/000090765426000102/form4.xml","form_type":"4"}},{"id":4618704,"issuer":{"id":3781,"kind":"organization","name":"Oruka Therapeutics, Inc.","symbol":"ORKA"},"owners":[{"id":23523,"kind":"person","name":"Agarwal Arjun","position":1,"cik":"0002033974","reported_name":"Agarwal Arjun","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President, Finance"}}],"security":"Employee Stock Option (right to buy)","published_at":"2026-09-15T23:17:27.000Z","date":"2026-09-11","kind":"exercise","planned":true,"acquired":false,"shares":1459,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"The option vests as to 1/48 of the underlying shares monthly from January 1, 2026."}],"balance_after":58333,"derivative":{"exercise_price":34.39,"expiration_date":"2036-01-22","underlying":"Common Stock","underlying_shares":1459},"source":{"system":"sec-edgar","filing":"0000907654-26-000097","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/2033974/000090765426000097/form4.xml","form_type":"4"}},{"id":4618703,"issuer":{"id":3781,"kind":"organization","name":"Oruka Therapeutics, Inc.","symbol":"ORKA"},"owners":[{"id":23523,"kind":"person","name":"Agarwal Arjun","position":1,"cik":"0002033974","reported_name":"Agarwal Arjun","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President, Finance"}}],"security":"Employee Stock Option (right to buy)","published_at":"2026-09-15T23:17:27.000Z","date":"2026-09-11","kind":"exercise","planned":true,"acquired":false,"shares":8000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The option vests as to 1/48 of the underlying shares monthly from January 1, 2025."}],"balance_after":84917,"derivative":{"exercise_price":12.5,"expiration_date":"2035-01-21","underlying":"Common Stock","underlying_shares":8000},"source":{"system":"sec-edgar","filing":"0000907654-26-000097","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/2033974/000090765426000097/form4.xml","form_type":"4"}},{"id":4618702,"issuer":{"id":3781,"kind":"organization","name":"Oruka Therapeutics, Inc.","symbol":"ORKA"},"owners":[{"id":23523,"kind":"person","name":"Agarwal Arjun","position":1,"cik":"0002033974","reported_name":"Agarwal Arjun","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President, Finance"}}],"security":"Common Stock","published_at":"2026-09-15T23:17:27.000Z","date":"2026-09-15","kind":"sale","planned":true,"acquired":false,"shares":560,"price":95.71,"value":53597.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F6","text":"The reported sales were effected pursuant to Oruka Therapeutics, Inc.'s automatic, non-discretionary, sell-to-cover procedure to satisfy tax withholding obligations arising in connection with the vesting of restricted stock units."}],"balance_after":14752,"source":{"system":"sec-edgar","filing":"0000907654-26-000097","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/2033974/000090765426000097/form4.xml","form_type":"4"}},{"id":4618701,"issuer":{"id":3781,"kind":"organization","name":"Oruka Therapeutics, Inc.","symbol":"ORKA"},"owners":[{"id":23523,"kind":"person","name":"Agarwal Arjun","position":1,"cik":"0002033974","reported_name":"Agarwal Arjun","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President, Finance"}}],"security":"Common Stock","published_at":"2026-09-15T23:17:27.000Z","date":"2026-09-11","kind":"sale","planned":true,"acquired":false,"shares":200,"price":94.015,"value":18803.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These sales were effected pursuant to a Rule 10b5-1 trading plan entered into on February 11, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $93.98 to $94.05, inclusive."}],"balance_after":15312,"source":{"system":"sec-edgar","filing":"0000907654-26-000097","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/2033974/000090765426000097/form4.xml","form_type":"4"}},{"id":4618700,"issuer":{"id":3781,"kind":"organization","name":"Oruka Therapeutics, Inc.","symbol":"ORKA"},"owners":[{"id":23523,"kind":"person","name":"Agarwal Arjun","position":1,"cik":"0002033974","reported_name":"Agarwal Arjun","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President, Finance"}}],"security":"Common Stock","published_at":"2026-09-15T23:17:27.000Z","date":"2026-09-11","kind":"sale","planned":true,"acquired":false,"shares":2208,"price":93.2611,"value":205920.5088,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These sales were effected pursuant to a Rule 10b5-1 trading plan entered into on February 11, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $92.775 to $93.40, inclusive."}],"balance_after":15512,"source":{"system":"sec-edgar","filing":"0000907654-26-000097","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/2033974/000090765426000097/form4.xml","form_type":"4"}},{"id":4618699,"issuer":{"id":3781,"kind":"organization","name":"Oruka Therapeutics, Inc.","symbol":"ORKA"},"owners":[{"id":23523,"kind":"person","name":"Agarwal Arjun","position":1,"cik":"0002033974","reported_name":"Agarwal Arjun","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President, Finance"}}],"security":"Common Stock","published_at":"2026-09-15T23:17:27.000Z","date":"2026-09-11","kind":"sale","planned":true,"acquired":false,"shares":4051,"price":92.4135,"value":374367.0885,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These sales were effected pursuant to a Rule 10b5-1 trading plan entered into on February 11, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $91.74 to $92.71, inclusive."}],"balance_after":17720,"source":{"system":"sec-edgar","filing":"0000907654-26-000097","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/2033974/000090765426000097/form4.xml","form_type":"4"}},{"id":4618698,"issuer":{"id":3781,"kind":"organization","name":"Oruka Therapeutics, Inc.","symbol":"ORKA"},"owners":[{"id":23523,"kind":"person","name":"Agarwal Arjun","position":1,"cik":"0002033974","reported_name":"Agarwal Arjun","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President, Finance"}}],"security":"Common Stock","published_at":"2026-09-15T23:17:27.000Z","date":"2026-09-11","kind":"sale","planned":true,"acquired":false,"shares":3000,"price":91.1073,"value":273321.9,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These sales were effected pursuant to a Rule 10b5-1 trading plan entered into on February 11, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $90.71 to $91.50, inclusive. The reporting person undertakes to provide to Oruka Therapeutics, Inc., any security holder of Oruka Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3), (4) and (5) to this Form 4."}],"balance_after":21771,"source":{"system":"sec-edgar","filing":"0000907654-26-000097","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2033974/000090765426000097/form4.xml","form_type":"4"}},{"id":4618697,"issuer":{"id":3781,"kind":"organization","name":"Oruka Therapeutics, Inc.","symbol":"ORKA"},"owners":[{"id":23523,"kind":"person","name":"Agarwal Arjun","position":1,"cik":"0002033974","reported_name":"Agarwal Arjun","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President, Finance"}}],"security":"Common Stock","published_at":"2026-09-15T23:17:27.000Z","date":"2026-09-11","kind":"exercise","planned":true,"acquired":true,"shares":1459,"price":34.39,"value":50175.01,"ownership":{"direct":true},"balance_after":24771,"source":{"system":"sec-edgar","filing":"0000907654-26-000097","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2033974/000090765426000097/form4.xml","form_type":"4"}},{"id":4618696,"issuer":{"id":3781,"kind":"organization","name":"Oruka Therapeutics, Inc.","symbol":"ORKA"},"owners":[{"id":23523,"kind":"person","name":"Agarwal Arjun","position":1,"cik":"0002033974","reported_name":"Agarwal Arjun","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President, Finance"}}],"security":"Common Stock","published_at":"2026-09-15T23:17:27.000Z","date":"2026-09-11","kind":"exercise","planned":true,"acquired":true,"shares":8000,"price":12.5,"value":100000.0,"ownership":{"direct":true},"balance_after":23312,"source":{"system":"sec-edgar","filing":"0000907654-26-000097","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2033974/000090765426000097/form4.xml","form_type":"4"}},{"id":687391,"issuer":{"id":3781,"kind":"organization","name":"Oruka Therapeutics, Inc.","symbol":"ORKA"},"owners":[{"id":23523,"kind":"person","name":"Agarwal Arjun","position":1,"cik":"0002033974","reported_name":"Agarwal Arjun","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President, Finance"}}],"security":"Employee Stock Option (right to buy)","published_at":"2026-08-14T21:42:56.000Z","date":"2026-08-13","kind":"exercise","planned":true,"acquired":false,"shares":1458,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"The option vests as to 1/48 of the underlying shares monthly from January 1, 2026."}],"balance_after":59792,"derivative":{"exercise_price":34.39,"expiration_date":"2036-01-22","underlying":"Common Stock","underlying_shares":1458},"source":{"system":"sec-edgar","filing":"0000907654-26-000075","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/907654/000090765426000075/form4.xml","form_type":"4"}},{"id":687390,"issuer":{"id":3781,"kind":"organization","name":"Oruka Therapeutics, Inc.","symbol":"ORKA"},"owners":[{"id":23523,"kind":"person","name":"Agarwal Arjun","position":1,"cik":"0002033974","reported_name":"Agarwal Arjun","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President, Finance"}}],"security":"Employee Stock Option (right to buy)","published_at":"2026-08-14T21:42:56.000Z","date":"2026-08-13","kind":"exercise","planned":true,"acquired":false,"shares":8542,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The option vests as to 1/48 of the underlying shares monthly from January 1, 2025."}],"balance_after":92917,"derivative":{"exercise_price":12.5,"expiration_date":"2035-01-21","underlying":"Common Stock","underlying_shares":8542},"source":{"system":"sec-edgar","filing":"0000907654-26-000075","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/907654/000090765426000075/form4.xml","form_type":"4"}},{"id":687389,"issuer":{"id":3781,"kind":"organization","name":"Oruka Therapeutics, Inc.","symbol":"ORKA"},"owners":[{"id":23523,"kind":"person","name":"Agarwal Arjun","position":1,"cik":"0002033974","reported_name":"Agarwal Arjun","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President, Finance"}}],"security":"Common Stock","published_at":"2026-08-14T21:42:56.000Z","date":"2026-08-13","kind":"sale","planned":true,"acquired":false,"shares":2358,"price":108.4628,"value":255755.2824,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These sales were effected pursuant to a Rule 10b5-1 trading plan entered into on February 11, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $108.24 to $108.71, inclusive."}],"balance_after":15312,"source":{"system":"sec-edgar","filing":"0000907654-26-000075","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/907654/000090765426000075/form4.xml","form_type":"4"}},{"id":687388,"issuer":{"id":3781,"kind":"organization","name":"Oruka Therapeutics, Inc.","symbol":"ORKA"},"owners":[{"id":23523,"kind":"person","name":"Agarwal Arjun","position":1,"cik":"0002033974","reported_name":"Agarwal Arjun","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President, Finance"}}],"security":"Common Stock","published_at":"2026-08-14T21:42:56.000Z","date":"2026-08-13","kind":"sale","planned":true,"acquired":false,"shares":2142,"price":107.7138,"value":230722.9596,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These sales were effected pursuant to a Rule 10b5-1 trading plan entered into on February 11, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $107.20 to $108.19, inclusive."}],"balance_after":17670,"source":{"system":"sec-edgar","filing":"0000907654-26-000075","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/907654/000090765426000075/form4.xml","form_type":"4"}},{"id":687387,"issuer":{"id":3781,"kind":"organization","name":"Oruka Therapeutics, Inc.","symbol":"ORKA"},"owners":[{"id":23523,"kind":"person","name":"Agarwal Arjun","position":1,"cik":"0002033974","reported_name":"Agarwal Arjun","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President, Finance"}}],"security":"Common Stock","published_at":"2026-08-14T21:42:56.000Z","date":"2026-08-13","kind":"sale","planned":true,"acquired":false,"shares":1268,"price":106.6255,"value":135201.134,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These sales were effected pursuant to a Rule 10b5-1 trading plan entered into on February 11, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $106.11 to $107.07, inclusive."}],"balance_after":19812,"source":{"system":"sec-edgar","filing":"0000907654-26-000075","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/907654/000090765426000075/form4.xml","form_type":"4"}},{"id":687386,"issuer":{"id":3781,"kind":"organization","name":"Oruka Therapeutics, Inc.","symbol":"ORKA"},"owners":[{"id":23523,"kind":"person","name":"Agarwal Arjun","position":1,"cik":"0002033974","reported_name":"Agarwal Arjun","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President, Finance"}}],"security":"Common Stock","published_at":"2026-08-14T21:42:56.000Z","date":"2026-08-13","kind":"sale","planned":true,"acquired":false,"shares":2132,"price":105.5716,"value":225078.6512,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These sales were effected pursuant to a Rule 10b5-1 trading plan entered into on February 11, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $105.11 to $106.08, inclusive."}],"balance_after":21080,"source":{"system":"sec-edgar","filing":"0000907654-26-000075","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/907654/000090765426000075/form4.xml","form_type":"4"}},{"id":687385,"issuer":{"id":3781,"kind":"organization","name":"Oruka Therapeutics, Inc.","symbol":"ORKA"},"owners":[{"id":23523,"kind":"person","name":"Agarwal Arjun","position":1,"cik":"0002033974","reported_name":"Agarwal Arjun","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President, Finance"}}],"security":"Common Stock","published_at":"2026-08-14T21:42:56.000Z","date":"2026-08-13","kind":"sale","planned":true,"acquired":false,"shares":2100,"price":104.6734,"value":219814.14,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These sales were effected pursuant to a Rule 10b5-1 trading plan entered into on February 11, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $104.05 to $104.99, inclusive. The reporting person undertakes to provide to Oruka Therapeutics, Inc., any security holder of Oruka Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3), (4), (5) and (6) to this Form 4."}],"balance_after":23212,"source":{"system":"sec-edgar","filing":"0000907654-26-000075","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/907654/000090765426000075/form4.xml","form_type":"4"}},{"id":687384,"issuer":{"id":3781,"kind":"organization","name":"Oruka Therapeutics, Inc.","symbol":"ORKA"},"owners":[{"id":23523,"kind":"person","name":"Agarwal Arjun","position":1,"cik":"0002033974","reported_name":"Agarwal Arjun","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President, Finance"}}],"security":"Common Stock","published_at":"2026-08-14T21:42:56.000Z","date":"2026-08-13","kind":"exercise","planned":true,"acquired":true,"shares":1458,"price":34.39,"value":50140.62,"ownership":{"direct":true},"balance_after":25312,"source":{"system":"sec-edgar","filing":"0000907654-26-000075","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/907654/000090765426000075/form4.xml","form_type":"4"}},{"id":687383,"issuer":{"id":3781,"kind":"organization","name":"Oruka Therapeutics, Inc.","symbol":"ORKA"},"owners":[{"id":23523,"kind":"person","name":"Agarwal Arjun","position":1,"cik":"0002033974","reported_name":"Agarwal Arjun","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President, Finance"}}],"security":"Common Stock","published_at":"2026-08-14T21:42:56.000Z","date":"2026-08-13","kind":"exercise","planned":true,"acquired":true,"shares":8542,"price":12.5,"value":106775.0,"ownership":{"direct":true},"balance_after":23854,"source":{"system":"sec-edgar","filing":"0000907654-26-000075","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/907654/000090765426000075/form4.xml","form_type":"4"}},{"id":710865,"issuer":{"id":3781,"kind":"organization","name":"Oruka Therapeutics, Inc.","symbol":"ORKA"},"owners":[{"id":23523,"kind":"person","name":"Agarwal Arjun","position":1,"cik":"0002033974","reported_name":"Agarwal Arjun","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President, Finance"}}],"security":"Employee Stock Option (right to buy)","published_at":"2026-07-13T21:09:26.000Z","date":"2026-07-13","kind":"exercise","planned":true,"acquired":false,"shares":1458,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The option vests as to 1/48 of the underlying shares monthly from January 1, 2026."}],"balance_after":61250,"derivative":{"exercise_price":34.39,"expiration_date":"2036-01-22","underlying":"Common Stock","underlying_shares":1458},"source":{"system":"sec-edgar","filing":"0000907654-26-000071","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/907654/000090765426000071/form4.xml","form_type":"4"}},{"id":710864,"issuer":{"id":3781,"kind":"organization","name":"Oruka Therapeutics, Inc.","symbol":"ORKA"},"owners":[{"id":23523,"kind":"person","name":"Agarwal Arjun","position":1,"cik":"0002033974","reported_name":"Agarwal Arjun","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President, Finance"}}],"security":"Employee Stock Option (right to buy)","published_at":"2026-07-13T21:09:26.000Z","date":"2026-07-13","kind":"exercise","planned":true,"acquired":false,"shares":8541,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The option vests as to 1/48 of the underlying shares monthly from January 1, 2025."}],"balance_after":101459,"derivative":{"exercise_price":12.5,"expiration_date":"2035-01-21","underlying":"Common Stock","underlying_shares":8541},"source":{"system":"sec-edgar","filing":"0000907654-26-000071","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/907654/000090765426000071/form4.xml","form_type":"4"}},{"id":710863,"issuer":{"id":3781,"kind":"organization","name":"Oruka Therapeutics, Inc.","symbol":"ORKA"},"owners":[{"id":23523,"kind":"person","name":"Agarwal Arjun","position":1,"cik":"0002033974","reported_name":"Agarwal Arjun","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President, Finance"}}],"security":"Common Stock","published_at":"2026-07-13T21:09:26.000Z","date":"2026-07-13","kind":"sale","planned":true,"acquired":false,"shares":300,"price":85.6333,"value":25689.99,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These sales were effected pursuant to a Rule 10b5-1 trading plan entered into on February 11, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $85.56 to $85.69, inclusive."}],"balance_after":15312,"source":{"system":"sec-edgar","filing":"0000907654-26-000071","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/907654/000090765426000071/form4.xml","form_type":"4"}},{"id":710862,"issuer":{"id":3781,"kind":"organization","name":"Oruka Therapeutics, Inc.","symbol":"ORKA"},"owners":[{"id":23523,"kind":"person","name":"Agarwal Arjun","position":1,"cik":"0002033974","reported_name":"Agarwal Arjun","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President, Finance"}}],"security":"Common Stock","published_at":"2026-07-13T21:09:26.000Z","date":"2026-07-13","kind":"sale","planned":true,"acquired":false,"shares":5656,"price":84.9012,"value":480201.1872,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These sales were effected pursuant to a Rule 10b5-1 trading plan entered into on February 11, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $84.54 to $85.50, inclusive."}],"balance_after":15612,"source":{"system":"sec-edgar","filing":"0000907654-26-000071","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/907654/000090765426000071/form4.xml","form_type":"4"}},{"id":710861,"issuer":{"id":3781,"kind":"organization","name":"Oruka Therapeutics, Inc.","symbol":"ORKA"},"owners":[{"id":23523,"kind":"person","name":"Agarwal Arjun","position":1,"cik":"0002033974","reported_name":"Agarwal Arjun","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President, Finance"}}],"security":"Common Stock","published_at":"2026-07-13T21:09:26.000Z","date":"2026-07-13","kind":"sale","planned":true,"acquired":false,"shares":3743,"price":84.2557,"value":315369.0851,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These sales were effected pursuant to a Rule 10b5-1 trading plan entered into on February 11, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $83.54 to $84.53, inclusive."}],"balance_after":21268,"source":{"system":"sec-edgar","filing":"0000907654-26-000071","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/907654/000090765426000071/form4.xml","form_type":"4"}},{"id":710860,"issuer":{"id":3781,"kind":"organization","name":"Oruka Therapeutics, Inc.","symbol":"ORKA"},"owners":[{"id":23523,"kind":"person","name":"Agarwal Arjun","position":1,"cik":"0002033974","reported_name":"Agarwal Arjun","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President, Finance"}}],"security":"Common Stock","published_at":"2026-07-13T21:09:26.000Z","date":"2026-07-13","kind":"sale","planned":true,"acquired":false,"shares":300,"price":83.0665,"value":24919.95,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These sales were effected pursuant to a Rule 10b5-1 trading plan entered into on February 11, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $82.49 to $83.37, inclusive. The reporting person undertakes to provide to Oruka Therapeutics, Inc., any security holder of Oruka Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3), (4) and (5) to this Form 4."}],"balance_after":25011,"source":{"system":"sec-edgar","filing":"0000907654-26-000071","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/907654/000090765426000071/form4.xml","form_type":"4"}},{"id":710859,"issuer":{"id":3781,"kind":"organization","name":"Oruka Therapeutics, Inc.","symbol":"ORKA"},"owners":[{"id":23523,"kind":"person","name":"Agarwal Arjun","position":1,"cik":"0002033974","reported_name":"Agarwal Arjun","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President, Finance"}}],"security":"Common Stock","published_at":"2026-07-13T21:09:26.000Z","date":"2026-07-13","kind":"exercise","planned":true,"acquired":true,"shares":1458,"price":34.39,"value":50140.62,"ownership":{"direct":true},"balance_after":25311,"source":{"system":"sec-edgar","filing":"0000907654-26-000071","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/907654/000090765426000071/form4.xml","form_type":"4"}},{"id":710858,"issuer":{"id":3781,"kind":"organization","name":"Oruka Therapeutics, Inc.","symbol":"ORKA"},"owners":[{"id":23523,"kind":"person","name":"Agarwal Arjun","position":1,"cik":"0002033974","reported_name":"Agarwal Arjun","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President, Finance"}}],"security":"Common Stock","published_at":"2026-07-13T21:09:26.000Z","date":"2026-07-13","kind":"exercise","planned":true,"acquired":true,"shares":8541,"price":12.5,"value":106762.5,"ownership":{"direct":true},"balance_after":23853,"source":{"system":"sec-edgar","filing":"0000907654-26-000071","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/907654/000090765426000071/form4.xml","form_type":"4"}},{"id":731129,"issuer":{"id":3781,"kind":"organization","name":"Oruka Therapeutics, Inc.","symbol":"ORKA"},"owners":[{"id":23523,"kind":"person","name":"Agarwal Arjun","position":1,"cik":"0002033974","reported_name":"Agarwal Arjun","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President, Finance"}}],"security":"Common Stock","published_at":"2026-06-22T23:59:37.000Z","date":"2026-06-22","kind":"sale","planned":true,"acquired":false,"shares":699,"price":82.145,"value":57419.355,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These sales were effected pursuant to a Rule 10b5-1 trading plan entered into on February 11, 2026."}],"balance_after":15312,"source":{"system":"sec-edgar","filing":"0000907654-26-000066","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/907654/000090765426000066/form4.xml","form_type":"4"}},{"id":731128,"issuer":{"id":3781,"kind":"organization","name":"Oruka Therapeutics, Inc.","symbol":"ORKA"},"owners":[{"id":23523,"kind":"person","name":"Agarwal Arjun","position":1,"cik":"0002033974","reported_name":"Agarwal Arjun","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President, Finance"}}],"security":"Common Stock","published_at":"2026-06-22T23:59:37.000Z","date":"2026-06-22","kind":"sale","planned":true,"acquired":false,"shares":888,"price":80.01,"value":71048.88,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These sales were effected pursuant to a Rule 10b5-1 trading plan entered into on February 11, 2026."}],"balance_after":16011,"source":{"system":"sec-edgar","filing":"0000907654-26-000066","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/907654/000090765426000066/form4.xml","form_type":"4"}},{"id":738574,"issuer":{"id":3781,"kind":"organization","name":"Oruka Therapeutics, Inc.","symbol":"ORKA"},"owners":[{"id":23523,"kind":"person","name":"Agarwal Arjun","position":1,"cik":"0002033974","reported_name":"Agarwal Arjun","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President, Finance"}}],"security":"Employee Stock Option (right to buy)","published_at":"2026-06-15T22:57:06.000Z","date":"2026-06-12","kind":"exercise","planned":true,"acquired":false,"shares":1459,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"The option vests as to 1/48 of the underlying shares monthly from January 1, 2026."}],"balance_after":62708,"derivative":{"exercise_price":34.39,"expiration_date":"2036-01-22","underlying":"Common Stock","underlying_shares":1459},"source":{"system":"sec-edgar","filing":"0000907654-26-000064","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/907654/000090765426000064/form4.xml","form_type":"4"}},{"id":738573,"issuer":{"id":3781,"kind":"organization","name":"Oruka Therapeutics, Inc.","symbol":"ORKA"},"owners":[{"id":23523,"kind":"person","name":"Agarwal Arjun","position":1,"cik":"0002033974","reported_name":"Agarwal Arjun","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President, Finance"}}],"security":"Employee Stock Option (right to buy)","published_at":"2026-06-15T22:57:06.000Z","date":"2026-06-12","kind":"exercise","planned":true,"acquired":false,"shares":8000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The option vests as to 1/48 of the underlying shares monthly from January 1, 2025."}],"balance_after":110000,"derivative":{"exercise_price":12.5,"expiration_date":"2035-01-21","underlying":"Common Stock","underlying_shares":8000},"source":{"system":"sec-edgar","filing":"0000907654-26-000064","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/907654/000090765426000064/form4.xml","form_type":"4"}},{"id":738572,"issuer":{"id":3781,"kind":"organization","name":"Oruka Therapeutics, Inc.","symbol":"ORKA"},"owners":[{"id":23523,"kind":"person","name":"Agarwal Arjun","position":1,"cik":"0002033974","reported_name":"Agarwal Arjun","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President, Finance"}}],"security":"Common Stock","published_at":"2026-06-15T22:57:06.000Z","date":"2026-06-15","kind":"sale","planned":true,"acquired":false,"shares":395,"price":69.69,"value":27527.55,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F6","text":"The reported sales were effected pursuant to Oruka Therapeutics, Inc.'s automatic, non-discretionary, sell-to-cover procedure to satisfy tax withholding obligations arising in connection with the vesting of restricted stock units."}],"balance_after":16899,"source":{"system":"sec-edgar","filing":"0000907654-26-000064","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/907654/000090765426000064/form4.xml","form_type":"4"}},{"id":738571,"issuer":{"id":3781,"kind":"organization","name":"Oruka Therapeutics, Inc.","symbol":"ORKA"},"owners":[{"id":23523,"kind":"person","name":"Agarwal Arjun","position":1,"cik":"0002033974","reported_name":"Agarwal Arjun","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President, Finance"}}],"security":"Common Stock","published_at":"2026-06-15T22:57:06.000Z","date":"2026-06-12","kind":"sale","planned":true,"acquired":false,"shares":3260,"price":70.3392,"value":229305.792,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"These sales were effected pursuant to a Rule 10b5-1 trading plan entered into on February 11, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $70.07 to $70.86, inclusive."}],"balance_after":17294,"source":{"system":"sec-edgar","filing":"0000907654-26-000064","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/907654/000090765426000064/form4.xml","form_type":"4"}},{"id":738570,"issuer":{"id":3781,"kind":"organization","name":"Oruka Therapeutics, Inc.","symbol":"ORKA"},"owners":[{"id":23523,"kind":"person","name":"Agarwal Arjun","position":1,"cik":"0002033974","reported_name":"Agarwal Arjun","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President, Finance"}}],"security":"Common Stock","published_at":"2026-06-15T22:57:06.000Z","date":"2026-06-12","kind":"sale","planned":true,"acquired":false,"shares":4340,"price":69.8512,"value":303154.208,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"These sales were effected pursuant to a Rule 10b5-1 trading plan entered into on February 11, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $69.07 to $70.06, inclusive."}],"balance_after":20554,"source":{"system":"sec-edgar","filing":"0000907654-26-000064","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/907654/000090765426000064/form4.xml","form_type":"4"}},{"id":738569,"issuer":{"id":3781,"kind":"organization","name":"Oruka Therapeutics, Inc.","symbol":"ORKA"},"owners":[{"id":23523,"kind":"person","name":"Agarwal Arjun","position":1,"cik":"0002033974","reported_name":"Agarwal Arjun","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President, Finance"}}],"security":"Common Stock","published_at":"2026-06-15T22:57:06.000Z","date":"2026-06-12","kind":"sale","planned":true,"acquired":false,"shares":1859,"price":68.3419,"value":127047.5921,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"These sales were effected pursuant to a Rule 10b5-1 trading plan entered into on February 11, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $67.87 to $68.71, inclusive. The reporting person undertakes to provide to Oruka Therapeutics, Inc., any security holder of Oruka Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (3), (4) and (5) to this Form 4."}],"balance_after":24894,"source":{"system":"sec-edgar","filing":"0000907654-26-000064","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/907654/000090765426000064/form4.xml","form_type":"4"}},{"id":738568,"issuer":{"id":3781,"kind":"organization","name":"Oruka Therapeutics, Inc.","symbol":"ORKA"},"owners":[{"id":23523,"kind":"person","name":"Agarwal Arjun","position":1,"cik":"0002033974","reported_name":"Agarwal Arjun","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President, Finance"}}],"security":"Common Stock","published_at":"2026-06-15T22:57:06.000Z","date":"2026-06-12","kind":"exercise","planned":true,"acquired":true,"shares":1459,"price":34.39,"value":50175.01,"ownership":{"direct":true},"balance_after":26753,"source":{"system":"sec-edgar","filing":"0000907654-26-000064","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/907654/000090765426000064/form4.xml","form_type":"4"}},{"id":738567,"issuer":{"id":3781,"kind":"organization","name":"Oruka Therapeutics, Inc.","symbol":"ORKA"},"owners":[{"id":23523,"kind":"person","name":"Agarwal Arjun","position":1,"cik":"0002033974","reported_name":"Agarwal Arjun","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President, Finance"}}],"security":"Common Stock","published_at":"2026-06-15T22:57:06.000Z","date":"2026-06-12","kind":"exercise","planned":true,"acquired":true,"shares":8000,"price":12.5,"value":100000.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 888 shares acquired under the Oruka Therapeutics, Inc. stock purchase plan on June 8, 2026."}],"balance_after":25294,"source":{"system":"sec-edgar","filing":"0000907654-26-000064","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/907654/000090765426000064/form4.xml","form_type":"4"}},{"id":775895,"issuer":{"id":3781,"kind":"organization","name":"Oruka Therapeutics, Inc.","symbol":"ORKA"},"owners":[{"id":23523,"kind":"person","name":"Agarwal Arjun","position":1,"cik":"0002033974","reported_name":"Agarwal Arjun","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President, Finance"}}],"security":"Employee Stock Option (right to buy)","published_at":"2026-05-18T22:07:57.000Z","date":"2026-05-18","kind":"exercise","planned":true,"acquired":false,"shares":5833,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The option vests as to 1/48 of the underlying shares monthly from January 1, 2026."}],"balance_after":64167,"derivative":{"exercise_price":34.39,"expiration_date":"2036-01-22","underlying":"Common Stock","underlying_shares":5833},"source":{"system":"sec-edgar","filing":"0000907654-26-000041","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/907654/000090765426000041/form4.xml","form_type":"4"}},{"id":775894,"issuer":{"id":3781,"kind":"organization","name":"Oruka Therapeutics, Inc.","symbol":"ORKA"},"owners":[{"id":23523,"kind":"person","name":"Agarwal Arjun","position":1,"cik":"0002033974","reported_name":"Agarwal Arjun","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President, Finance"}}],"security":"Employee Stock Option (right to buy)","published_at":"2026-05-18T22:07:57.000Z","date":"2026-05-18","kind":"exercise","planned":true,"acquired":false,"shares":2000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The option vests as to 1/48 of the underlying shares monthly from January 1, 2025."}],"balance_after":118000,"derivative":{"exercise_price":12.5,"expiration_date":"2035-01-21","underlying":"Common Stock","underlying_shares":2000},"source":{"system":"sec-edgar","filing":"0000907654-26-000041","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/907654/000090765426000041/form4.xml","form_type":"4"}},{"id":775893,"issuer":{"id":3781,"kind":"organization","name":"Oruka Therapeutics, Inc.","symbol":"ORKA"},"owners":[{"id":23523,"kind":"person","name":"Agarwal Arjun","position":1,"cik":"0002033974","reported_name":"Agarwal Arjun","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President, Finance"}}],"security":"Common Stock","published_at":"2026-05-18T22:07:57.000Z","date":"2026-05-18","kind":"sale","planned":true,"acquired":false,"shares":700,"price":61.1606,"value":42812.42,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These sales were effected pursuant to a Rule 10b5-1 trading plan entered into on February 11, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $60.82 to $61.76, inclusive."}],"balance_after":16406,"source":{"system":"sec-edgar","filing":"0000907654-26-000041","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/907654/000090765426000041/form4.xml","form_type":"4"}},{"id":775892,"issuer":{"id":3781,"kind":"organization","name":"Oruka Therapeutics, Inc.","symbol":"ORKA"},"owners":[{"id":23523,"kind":"person","name":"Agarwal Arjun","position":1,"cik":"0002033974","reported_name":"Agarwal Arjun","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President, Finance"}}],"security":"Common Stock","published_at":"2026-05-18T22:07:57.000Z","date":"2026-05-18","kind":"sale","planned":true,"acquired":false,"shares":800,"price":60.3364,"value":48269.12,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These sales were effected pursuant to a Rule 10b5-1 trading plan entered into on February 11, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $59.78 to $60.72, inclusive."}],"balance_after":17106,"source":{"system":"sec-edgar","filing":"0000907654-26-000041","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/907654/000090765426000041/form4.xml","form_type":"4"}},{"id":775891,"issuer":{"id":3781,"kind":"organization","name":"Oruka Therapeutics, Inc.","symbol":"ORKA"},"owners":[{"id":23523,"kind":"person","name":"Agarwal Arjun","position":1,"cik":"0002033974","reported_name":"Agarwal Arjun","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President, Finance"}}],"security":"Common Stock","published_at":"2026-05-18T22:07:57.000Z","date":"2026-05-18","kind":"sale","planned":true,"acquired":false,"shares":4600,"price":59.1869,"value":272259.74,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These sales were effected pursuant to a Rule 10b5-1 trading plan entered into on February 11, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $58.76 to $59.75, inclusive."}],"balance_after":17906,"source":{"system":"sec-edgar","filing":"0000907654-26-000041","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/907654/000090765426000041/form4.xml","form_type":"4"}},{"id":775890,"issuer":{"id":3781,"kind":"organization","name":"Oruka Therapeutics, Inc.","symbol":"ORKA"},"owners":[{"id":23523,"kind":"person","name":"Agarwal Arjun","position":1,"cik":"0002033974","reported_name":"Agarwal Arjun","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President, Finance"}}],"security":"Common Stock","published_at":"2026-05-18T22:07:57.000Z","date":"2026-05-18","kind":"sale","planned":true,"acquired":false,"shares":4190,"price":58.3449,"value":244465.131,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These sales were effected pursuant to a Rule 10b5-1 trading plan entered into on February 11, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $57.72 to $58.71, inclusive. The reporting person undertakes to provide to Oruka Therapeutics, Inc., any security holder of Oruka Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3), (4) and (5) to this Form 4."}],"balance_after":22506,"source":{"system":"sec-edgar","filing":"0000907654-26-000041","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/907654/000090765426000041/form4.xml","form_type":"4"}},{"id":775889,"issuer":{"id":3781,"kind":"organization","name":"Oruka Therapeutics, Inc.","symbol":"ORKA"},"owners":[{"id":23523,"kind":"person","name":"Agarwal Arjun","position":1,"cik":"0002033974","reported_name":"Agarwal Arjun","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President, Finance"}}],"security":"Common Stock","published_at":"2026-05-18T22:07:57.000Z","date":"2026-05-18","kind":"exercise","planned":true,"acquired":true,"shares":5833,"price":34.39,"value":200596.87,"ownership":{"direct":true},"balance_after":26696,"source":{"system":"sec-edgar","filing":"0000907654-26-000041","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/907654/000090765426000041/form4.xml","form_type":"4"}},{"id":775888,"issuer":{"id":3781,"kind":"organization","name":"Oruka Therapeutics, Inc.","symbol":"ORKA"},"owners":[{"id":23523,"kind":"person","name":"Agarwal Arjun","position":1,"cik":"0002033974","reported_name":"Agarwal Arjun","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President, Finance"}}],"security":"Common Stock","published_at":"2026-05-18T22:07:57.000Z","date":"2026-05-18","kind":"exercise","planned":true,"acquired":true,"shares":2000,"price":12.5,"value":25000.0,"ownership":{"direct":true},"balance_after":20863,"source":{"system":"sec-edgar","filing":"0000907654-26-000041","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/907654/000090765426000041/form4.xml","form_type":"4"}},{"id":839734,"issuer":{"id":3781,"kind":"organization","name":"Oruka Therapeutics, Inc.","symbol":"ORKA"},"owners":[{"id":23523,"kind":"person","name":"Agarwal Arjun","position":1,"cik":"0002033974","reported_name":"Agarwal Arjun","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President, Finance"}}],"security":"Common Stock","published_at":"2026-03-17T20:09:21.000Z","date":"2026-03-16","kind":"sale","planned":false,"acquired":false,"shares":395,"price":41.3,"value":16313.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported sales were effected pursuant to Oruka Therapeutics, Inc.'s automatic, non-discretionary, sell-to-cover procedure to satisfy tax withholding obligations arising in connection with the vesting of restricted stock units."}],"balance_after":18863,"source":{"system":"sec-edgar","filing":"0000907654-26-000032","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/907654/000090765426000032/form4.xml","form_type":"4"}},{"id":932715,"issuer":{"id":3781,"kind":"organization","name":"Oruka Therapeutics, Inc.","symbol":"ORKA"},"owners":[{"id":23523,"kind":"person","name":"Agarwal Arjun","position":1,"cik":"0002033974","reported_name":"Agarwal Arjun","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Finance"}}],"security":"Employee Stock Option (right to buy)","published_at":"2026-01-23T22:40:03.000Z","date":"2026-01-23","kind":"grant","planned":false,"acquired":true,"shares":70000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vests as to 1/48 of the underlying shares monthly from January 1, 2026."}],"balance_after":70000,"derivative":{"exercise_price":34.39,"expiration_date":"2036-01-22","underlying":"Common Stock","underlying_shares":70000},"source":{"system":"sec-edgar","filing":"0000907654-26-000016","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/907654/000090765426000016/form4.xml","form_type":"4"}},{"id":932714,"issuer":{"id":3781,"kind":"organization","name":"Oruka Therapeutics, Inc.","symbol":"ORKA"},"owners":[{"id":23523,"kind":"person","name":"Agarwal Arjun","position":1,"cik":"0002033974","reported_name":"Agarwal Arjun","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Finance"}}],"security":"Common Stock","published_at":"2026-01-23T22:40:03.000Z","date":"2026-01-23","kind":"grant","planned":false,"acquired":true,"shares":17500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The grant vests as to 1/16 of the shares on each March 14, June 14, September 14 and December 14 (or if not a trading day, the immediately preceding trading day)."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 1,758 shares acquired under the Oruka stock purchase plan on December 8, 2025."}],"balance_after":19258,"source":{"system":"sec-edgar","filing":"0000907654-26-000016","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/907654/000090765426000016/form4.xml","form_type":"4"}},{"id":1295914,"issuer":{"id":3781,"kind":"organization","name":"Oruka Therapeutics, Inc.","symbol":"ORKA"},"owners":[{"id":23523,"kind":"person","name":"Agarwal Arjun","position":1,"cik":"0002033974","reported_name":"Agarwal Arjun","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Finance"}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-01-24T21:44:41.000Z","date":"2025-01-22","kind":"grant","planned":false,"acquired":true,"shares":120000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests as to 1/48 of the underlying shares monthly from January 1, 2025."}],"balance_after":120000,"derivative":{"exercise_price":12.5,"expiration_date":"2035-01-21","underlying":"Common Stock","underlying_shares":120000},"source":{"system":"sec-edgar","filing":"0001062993-25-001089","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/907654/000106299325001089/form4.xml","form_type":"4"}}]}